ADVANTAGE DIAGNOSTICS CORPORATION ADC MULTIPLE DRUG TEST CARD (4013)

Specialty: Toxicology / TDM


Welcome to the PulseAid listing for the ADVANTAGE DIAGNOSTICS CORPORATION ADC MULTIPLE DRUG TEST CARD medical device. This device is used in the Toxicology / TDM healthcare specialty. Below, you can view the analytes this device is used to test, and its corresponding complexity (HIGH, MODERATE, or CLIA WAIVED). We have also randomly listed additional medical devices used in the Toxicology / TDM healthcare specialty at the bottom of the page.

Analytes Measured/Detected and Complexity:

ANALYTECOMPLEXITY
Cannabinoids (THC) (K023712 | K023712) CLIA WAIVED
Effective Date: 2004-02-24
Cocaine metabolites (K023712 | K023712) CLIA WAIVED
Effective Date: 2004-02-24
Methamphetamines (K023712 | K023712) CLIA WAIVED
Effective Date: 2004-02-24
Opiates (K023712 | K023712) CLIA WAIVED
Effective Date: 2004-02-24
Phencyclidine (PCP) (K023712 | K023712) CLIA WAIVED
Effective Date: 2004-02-24

Other Toxicology / TDM Devices:

Medical DeviceComplexity
Roche Diagnostics Cobas MiraView Complexity
LifeSign, Status Assure Drug Screen CardView Complexity
Redwood Toxicology Laboratory Reditest Redicup Substance Abuse Screening DeviceView Complexity
ROCHE DIAGNOSTICS COBAS BIOView Complexity
Phamatech QuickScreen (Model 9346Z)View Complexity
Biotechnostix, Inc. Rapid Response One Step Multi-Drug, Multi-Line Screen Test DeviceView Complexity
Beckman Coulter AU640View Complexity
BECKMAN SYNCHRON CX 9 ALX SYSTEMView Complexity
Amedica Biotech, Inc. Amedicheck Drug Screen Test CupView Complexity
Native Diagnostics International; DrugSmart Drug Screen Cup Tests with OPI 2000View Complexity